Back

Frailty and pre-frailty improvement after pulmonary vein isolation in elderly patients with atrial fibrillation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Catheter ablation in atrial fibrillation (1) Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yusuke Okuyama

Uji Tokushukai Medical Center, Uji (Japan)

6 More presentations in this session

Presentation thumbnail
Prognostic value of cardiac sympathetic nervous system in atrial fibrillation recurrence after catheter ablation.
Doctor Y. Fukuda (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Sex-specific differences in left atrial remodeling and implications for arrhythmia outcome prediction following circumferential pulmonary vein isolation
Doctor T. Huang (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation recurrence following repeat catheter ablation: a systematic review and meta-analysis
Doctor P. Ansusinha (Krung Thep Maha Nakhon, TH)
Abstract Slides Video
Presentation thumbnail
P-Wave Area Index as a predictor of recurrence after pulmonary vein isolation
Doctor T. Seewoester (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Repeat ablation outcomes following prior pulsed field ablation using either a circular over-the-wire or pentaspline ablation catheter
Ms M. Van Der Graaf (Nieuwegein, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation in atrial fibrillation (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Acute procedural outcomes of pulsed field ablation in elderly patients with atrial fibrillation: sub-analysis of the global FARADISE registry
thumbnail
Congress Presentation
Outcomes of pulmonary vein isolation procedures in the elderly - introduction of the biological AGE-Reader.
thumbnail
Congress Session
Registries, observational, and other studies on frailty, falls, and sarcopenia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources